Literature DB >> 28509307

AP-VAS 2012 case report: MPO-ANCA-negative relapse of MPO-ANCA-associated vasculitis.

Yoshinori Komagata1, Kazufumi Nomura2, Ken Yoshihara2, Soko Kawashima2, Shinya Kaname2, Yoshihiro Arimura2, Akira Yamada2.   

Abstract

A 79-year-old female was admitted to our hospital with fever, proteinuria, hematuria, high levels of C-reactive protein (CRP), and high titer of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA). Our diagnosis was microscopic polyangiitis (MPA) and she was treated with steroid pulse therapy. Clinical remission was induced; however, the disease relapsed with saddle nose and necrotizing vasculitis of the nasal cavity mucosa 1 year later. Although there was no elevation of the MPO-ANCA titer, we diagnosed the patient with relapse of MPO-ANCA-positive granulomatosis with polyangiitis (GPA). Remission was induced again with steroids and azathioprine. It has been reported that the number of MPO-ANCA-positive patients in Asian countries is relatively higher than in Western countries. We checked 29 GPA patients in our hospital and 9 patients (31.0 %) were MPO-ANCA-positive. In addition, it is not rare that an ANCA-associated vasculitis (AAV) patient who has been in remission with negative ANCA relapses without any elevation of ANCA titer. We checked the transition of ANCA titer of 24 AAV patients in our hospital who relapsed and 6 patients (25 %) relapsed without any elevation of ANCA titer. We should be careful for a relapse, even if the ANCA titer remains negative. It is also possible that ANCA had been changed so as not to be detected by the same enzyme-linked immunosorbent assay (ELISA) kit. Thus, it is also important to change the detection system if clinical symptoms are worsened while ANCA is still negative.

Entities:  

Keywords:  ANCA-associated vasculitis; ELISA; MPO-ANCA-positive GPA; Relapse

Year:  2013        PMID: 28509307      PMCID: PMC5411547          DOI: 10.1007/s13730-013-0100-3

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  15 in total

1.  Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis.

Authors:  G Gaskin; C O Savage; J J Ryan; S Jones; A J Rees; C M Lockwood; C D Pusey
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

Review 2.  [ANCA associated vasculitis and PRGN].

Authors:  Yoshihiro Arimura; Souko Kawashima; Ken Yoshihara
Journal:  Nihon Jinzo Gakkai Shi       Date:  2009

3.  Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.

Authors:  Min Chen; Feng Yu; Su-Xia Wang; Wan-Zhong Zou; Ying Zhang; Ming-Hui Zhao; Hai-Yan Wang
Journal:  Nephrol Dial Transplant       Date:  2006-09-15       Impact factor: 5.992

4.  Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.

Authors:  M M Boomsma; C A Stegeman; M J van der Leij; W Oost; J Hermans; C G Kallenberg; P C Limburg; J W Tervaert
Journal:  Arthritis Rheum       Date:  2000-09

5.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

6.  ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes.

Authors:  Kunihiro Yamagata; Joichi Usui; Chie Saito; Naoto Yamaguchi; Kouichi Hirayama; Kaori Mase; Masaki Kobayashi; Akio Koyama; Hitoshi Sugiyama; Kosaku Nitta; Takashi Wada; Eri Muso; Yoshihiro Arimura; Hirofumi Makino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2012-02-18       Impact factor: 2.801

7.  Patient with antibody-negative relapse of Goodpasture syndrome.

Authors:  K Benz; K Amann; K Dittrich; C Hugo; K Schnur; J Dötsch
Journal:  Clin Nephrol       Date:  2007-04       Impact factor: 0.975

8.  Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.

Authors:  Javier D Finkielman; Peter A Merkel; Darrell Schroeder; Gary S Hoffman; Robert Spiera; E William St Clair; John C Davis; W Joseph McCune; Andrea K Lears; Steven R Ytterberg; Amber M Hummel; Margaret A Viss; Tobias Peikert; John H Stone; Ulrich Specks
Journal:  Ann Intern Med       Date:  2007-11-06       Impact factor: 25.391

9.  A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  J Damoiseaux; C Dähnrich; A Rosemann; C Probst; L Komorowski; C A Stegeman; K Egerer; F Hiepe; P van Paassen; W Stöcker; W Schlumberger; J W Cohen Tervaert
Journal:  Ann Rheum Dis       Date:  2008-03-28       Impact factor: 19.103

10.  Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.

Authors:  Won K Han; Hyon K Choi; Rachel M Roth; Robert T McCluskey; John L Niles
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

View more
  2 in total

1.  Granulomatosis with Polyangiitis Complicated by Hypertrophic Pachymeningitis Presenting with Simultaneous Multiple Intracerebral Hemorrhages.

Authors:  Eri Kato; Koichiro Tahara; Haeru Hayashi; Aki Shoji; Hiroaki Mori; Tetsuji Sawada
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

2.  Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report.

Authors:  Xiao-Li Li; Peng-Cheng Xu; Tong Chen; Tie-Kun Yan; Jian-Qing Jiang; Jun-Ya Jia; Li Wei; Wen-Ya Shang; Shui-Yi Hu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.